| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |